Biora Therapeutics has reported important developments in its BT-600 program and BioJet platform throughout its latest earnings name. The corporate introduced profitable Part I...
David Kirn, the Chief Government Officer of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), has bought a complete of $290,598 price of firm inventory, in accordance...
Tempest Therapeutics, Inc. (NASDAQ:TPST), an organization specializing in pharmaceutical preparations, has reported a notable inventory transaction involving its Chief Medical Officer, Whiting Samuel. In...
REDWOOD CITY, CA – Jasper Therapeutics, Inc. (NASDAQ:JSPR) Chief Working Officer Jeetinder Singh Mahal has bought 900 shares of the corporate's widespread inventory, based...
On Tuesday, Stifel, a monetary companies agency, downgraded shares of Calliditas Therapeutics (NASDAQ:CALT) from "Buy" to "Hold," adjusting the worth goal to $40, down...
